Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
4.305
-0.025 (-0.58%)
Dec 24, 2025, 4:00 PM EST - Market closed

Orchestra BioMed Holdings Revenue

Orchestra BioMed Holdings had revenue of $861.00K in the quarter ending September 30, 2025, a decrease of -12.77%. This brings the company's revenue in the last twelve months to $2.82M, up 6.46% year-over-year. In the year 2024, Orchestra BioMed Holdings had annual revenue of $2.64M, down -4.42%.

Revenue (ttm)
$2.82M
Revenue Growth
+6.46%
P/S Ratio
64.18
Revenue / Employee
$40,257
Employees
70
Market Cap
244.49M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20242.64M-122.00K-4.42%
Dec 31, 20232.76M-773.00K-21.88%
Dec 31, 20223.53M4.32M-
Dec 31, 2021-782.00K-6.49M-
Dec 31, 20205.70M--